Breaking News Instant updates and real-time market news.

ICHR

Ichor Holdings

$23.23

1.89 (8.86%)

09:09
02/13/18
02/13
09:09
02/13/18
09:09

Ichor Holdings upgraded to Strong Buy at Needham on stock price pullback

As reported earlier, Needham analyst Y. Edwin Mok upgraded Ichor Holdings to Strong Buy from Buy with a $42 price target. Mok notes that the selloff after a "solid" Q4 earnings report based on fears of a peaking business is unfounded, while the stock price already reflects some anticipated slowdown in earnings growth. The analyst adds that there are growth drivers being ignored by the market, such as revenue synergies from the company's acquisitions and the company's proprietary Liquid Delivery Module winning new designs.

ICHR Ichor Holdings
$23.23

1.89 (8.86%)

02/13/18
NEED
02/13/18
UPGRADE
NEED
Strong Buy
Ichor Holdings upgraded to Strong Buy from Buy at Needham
01/22/18
DADA
01/22/18
NO CHANGE
Target $235
DADA
Buy
Lam Research price target raised to $235 from $225 at DA Davidson
DA Davidson analyst Thomas Diffely raised his price target on Lam Research (LRCX) to $235 ahead of this week's Q2 earnings, saying the company should once again outperform the strong WFE spending levels as high performance computing in AI/big data, Internet of Things technologies, and China growth all make a contribution in the quarter. The analyst is especially bullish on the "monster Q3" after some "modest digestion" in Q1, citing strong equipment orders from TSMC (TSM) and much higher than expected guidance from Ichor Holdings (ICHR). Diffely keeps his Buy rating on Lam Research.
01/19/18
NEED
01/19/18
NO CHANGE
Target $42
NEED
Buy
Ichor Holdings price target raised to $42 from $36 at Needham
Needham analyst Y. Edwin Mok raised his price target on Ichor Holdings to $42 following a "very robust" Q1 outlook provided by the company ahead of the Needham Growth Conference meetings that was driven by strong demand, new program wins, and the full ramp of recent acquisitions. Mok keeps his Buy rating on Ichor, citing the company's "solid momentum and a validated inorganic growth strategy".
12/20/17
RBCM
12/20/17
NO CHANGE
RBCM
RBC says Applied Materials, Lam Research to benefit from continued memory capex
RBC Capital analyst Amit Daryanani, in analyzing the read-throughs from Micron's (MU) earnings report to others in the semiconductors sector, said he believes continued DRAM and NAND capital spending will benefit Applied Materials (AMAT) and Lam Research (LRCX) the most, adding that he sees Ichor Holdings (ICHR) as likely to be an indirect beneficiary as well given that those two account for the far majority of Ichor's sales.

TODAY'S FREE FLY STORIES

12:28
02/20/18
02/20
12:28
02/20/18
12:28
Conference/Events
Cantor analysts to hold an analyst/industry conference call »

Analysts, along with…

QTNA

Quantenna Communications

$14.10

0.01 (0.07%)

12:27
02/20/18
02/20
12:27
02/20/18
12:27
Conference/Events
Quantenna Communications management to meet with Benchmark »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 21

    Feb

  • 22

    Feb

  • 26

    Feb

  • 11

    Mar

BHP

BHP Billiton

$46.62

-2.07 (-4.25%)

12:25
02/20/18
02/20
12:25
02/20/18
12:25
Downgrade
BHP Billiton rating change  »

BHP Billiton downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QNTA

Quanta Capital Hldgs

12:25
02/20/18
02/20
12:25
02/20/18
12:25
Conference/Events
Quanta Capital Hldgs management to meet with Benchmark »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRVL

Marvell

$22.68

-0.06 (-0.26%)

12:25
02/20/18
02/20
12:25
02/20/18
12:25
Options
Marvell call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 08

    Mar

MRVL

Marvell

$22.68

-0.06 (-0.26%)

, CAVM

Cavium

$87.16

-0.09 (-0.10%)

12:25
02/20/18
02/20
12:25
02/20/18
12:25
Conference/Events
Cavium to host special shareholder meeting »

Special Shareholder…

MRVL

Marvell

$22.68

-0.06 (-0.26%)

CAVM

Cavium

$87.16

-0.09 (-0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

  • 08

    Mar

12:25
02/20/18
02/20
12:25
02/20/18
12:25
Conference/Events
UBS airlines analyst holds an analyst/industry conference call »

Analyst Genovesi, along…

SCI

Service Corp.

$38.65

-0.2 (-0.51%)

12:25
02/20/18
02/20
12:25
02/20/18
12:25
Conference/Events
Service Corp. to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 26

    Feb

  • 04

    Mar

WMT

Walmart

$95.22

-9.56 (-9.12%)

12:21
02/20/18
02/20
12:21
02/20/18
12:21
Recommendations
Walmart analyst commentary  »

Walmart e-commerce…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 25

    Feb

  • 28

    Feb

  • 07

    Mar

  • 18

    Mar

WMT

Walmart

$95.23

-9.55 (-9.11%)

, HD

Home Depot

$189.64

2.67 (1.43%)

12:17
02/20/18
02/20
12:17
02/20/18
12:17
General news
On The Fly: Top stock stories at midday »

Stocks opened deep in…

WMT

Walmart

$95.23

-9.55 (-9.11%)

HD

Home Depot

$189.64

2.67 (1.43%)

NXPI

NXP Semiconductors

$118.50

1.58 (1.35%)

QCOM

Qualcomm

$64.85

-0.43 (-0.66%)

AVGO

Broadcom

$248.89

-2.94 (-1.17%)

RAD

Rite Aid

$2.21

0.0801 (3.76%)

MDXG

MiMedx

$14.47

-0.96 (-6.22%)

UBNT

Ubiquiti

$74.04

-1.25 (-1.66%)

VYGR

Voyager Therapeutics

$19.36

0.19 (0.99%)

ABBV

AbbVie

$120.79

2.19 (1.85%)

FOGO

Fogo De Chao

$12.55

-0.15 (-1.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 25

    Feb

  • 28

    Feb

  • 06

    Mar

  • 07

    Mar

  • 08

    Mar

  • 14

    Mar

  • 18

    Mar

  • 22

    Mar

  • 23

    Mar

  • 27

    Mar

  • 28

    Mar

  • 30

    May

$NSD

NASDAQ Market Internals

12:17
02/20/18
02/20
12:17
02/20/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

12:16
02/20/18
02/20
12:16
02/20/18
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VALE

Vale

$14.23

0.105 (0.74%)

12:15
02/20/18
02/20
12:15
02/20/18
12:15
Options
Vale put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EFII

Electronics for Imaging

$28.11

0.04 (0.14%)

12:10
02/20/18
02/20
12:10
02/20/18
12:10
Conference/Events
Electronics for Imaging management to meet with Loop Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 26

    Feb

  • 06

    Mar

  • 07

    Mar

  • 08

    Mar

  • 13

    Mar

  • 14

    Mar

BHP

BHP Billiton

$46.89

-1.8 (-3.70%)

12:09
02/20/18
02/20
12:09
02/20/18
12:09
Downgrade
BHP Billiton rating change  »

BHP Billiton downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYL

Mylan

$41.63

-0.51 (-1.21%)

12:05
02/20/18
02/20
12:05
02/20/18
12:05
Options
Mylan call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

  • 13

    Nov

12:05
02/20/18
02/20
12:05
02/20/18
12:05
General news
Euro$ interest rate futures are mostly lower »

Euro$ interest rate…

SYNT

Syntel

$26.87

1.16 (4.51%)

12:03
02/20/18
02/20
12:03
02/20/18
12:03
Conference/Events
Syntel management to meet with Loop Capital »

Group luncheon to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

HSIC

Henry Schein

$69.52

1.14 (1.67%)

12:00
02/20/18
02/20
12:00
02/20/18
12:00
Downgrade
Henry Schein rating change  »

Henry Schein downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

12:00
02/20/18
02/20
12:00
02/20/18
12:00
General news
FX Action: USD-JPY »

FX Action: USD-JPY has…

GPS

Gap

$32.18

-1.0899 (-3.28%)

11:58
02/20/18
02/20
11:58
02/20/18
11:58
Recommendations
Gap analyst commentary  »

Jefferies remains buyer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

  • 18

    Mar

HSIC

Henry Schein

$69.52

1.14 (1.67%)

11:55
02/20/18
02/20
11:55
02/20/18
11:55
Downgrade
Henry Schein rating change  »

Henry Schein downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

OZM

Och-Ziff Capital

$2.56

-0.035 (-1.35%)

11:55
02/20/18
02/20
11:55
02/20/18
11:55
Conference/Events
CFA Society of Columbus to hold a luncheon meeting »

Group Luncheon with guest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

DBVT

DBV Technologies

$25.86

-0.29 (-1.11%)

, AIMT

Aimmune

$37.20

-1.04 (-2.72%)

11:54
02/20/18
02/20
11:54
02/20/18
11:54
Recommendations
DBV Technologies, Aimmune analyst commentary  »

DBV Technologies wins…

DBVT

DBV Technologies

$25.86

-0.29 (-1.11%)

AIMT

Aimmune

$37.20

-1.04 (-2.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 02

    Mar

  • 11

    Mar

KEYW

KEYW

$7.51

0.01 (0.13%)

11:53
02/20/18
02/20
11:53
02/20/18
11:53
Conference/Events
KEYW management to meet with Maxim »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    Feb

  • 15

    Mar

  • 14

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.